Preview Mode Links will not work in preview mode

This Week in Cardiology

May 24, 2024

Clues in SCAF, a DOAC antidote trial, another negative lytic trial in stroke, JAMA changes to observational studies, and BP in stroke care are the topics John Mandrola, MD, covers in this week’s podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. ARTESIA Substudy

Sadly, ARTESIA Doesn't Answer a Common Question in Cardiology

  • ARTESIA Substudy
  • NOAH

II. DOAC Reversal

  • ANNEXA-1 Trial

III. Lytic Therapy in Acute Stroke

Thrombolysis Offers No Benefit for Mild Stroke

  • TEMPO-2 Trial
  • The Case Against Thrombolytic Therapy in Stroke

IV. Observational Research

  • JAMA Special Communication
  • JAMA editors note

V. Aggressive BP Control in Stroke

Guidelines on Rapid BP Reduction in Acute Ischemic Stroke Challenged

  • TRUTH Trial

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact